Parkinson's Disease: Molecular mechanism, Biomarkers, and advances in therapeutic Development

Parkinson’s disease (PD) is the second most common neurodegenerative disorder and a rising global health challenge, owing to population aging and increasing disease prevalence. Existing therapeutic strategies provide mainly symptomatic relief, but significant progress has been made in understanding the molecular and cellular mechanisms underlying PD that has accelerated the development of disease-modifying interventions. This review summarizes the recent progress in PD research, including advances in disease pathogenesis, biomarker discovery, therapeutic development, and precision medicine. We discuss the complex interplay between α-synuclein aggregation, mitochondrial dysfunction, oxidative stress, neuroinflammation, impaired autophagy-lysosomal and ubiquitin-proteasome systems, dysregulation of the gut-brain axis, and genetic susceptibility as the basis of disease progression. Recent advances in genetic profiling and multi-omics technologies have greatly improved our understanding of disease heterogeneity and identified novel therapeutic targets. The review also provides an overview of established and emerging biomarkers including cerebrospinal fluid α-synuclein seed amplification assays, neurofilament light chain, neuroimaging modalities, digital biomarkers, wearable technologies and artificial intelligenceassisted diagnostic approaches for facilitating early diagnosis and disease monitoring.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24338876
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Parkinson's Disease: Molecular mechanism, Biomarkers, and advances in therapeutic Development

Neerja Kumari, Ankita Tripathi, Mukul Tambe, Anmol Singh et al.
3 links
Zenodo (CERN European Organization for Nuclear Research)
Parkinson's Disease Mechanisms and Treatments
article

Parkinson's Disease: Molecular mechanism, Biomarkers, and advances in therapeutic Development

Neerja Kumari, Ankita Tripathi, Mukul Tambe, Anmol Singh, Pankaj Singh, Jyoti Singh
article en

Abstract

Parkinson’s disease (PD) is the second most common neurodegenerative disorder and a rising global health challenge, owing to population aging and increasing disease prevalence. Existing therapeutic strategies provide mainly symptomatic relief, but significant progress has been made in understanding the molecular and cellular mechanisms underlying PD that has accelerated the development of disease-modifying interventions. This review summarizes the recent progress in PD research, including advances in disease pathogenesis, biomarker discovery, therapeutic development, and precision medicine. We discuss the complex interplay between α-synuclein aggregation, mitochondrial dysfunction, oxidative stress, neuroinflammation, impaired autophagy-lysosomal and ubiquitin-proteasome systems, dysregulation of the gut-brain axis, and genetic susceptibility as the basis of disease progression. Recent advances in genetic profiling and multi-omics technologies have greatly improved our understanding of disease heterogeneity and identified novel therapeutic targets. The review also provides an overview of established and emerging biomarkers including cerebrospinal fluid α-synuclein seed amplification assays, neurofilament light chain, neuroimaging modalities, digital biomarkers, wearable technologies and artificial intelligenceassisted diagnostic approaches for facilitating early diagnosis and disease monitoring.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon